Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher L Morton

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Pediatric Blood & Cancer|December 23, 2011
Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing ProgramStephen T Keir, Christopher L Morton, Jianrong Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
p53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)Monika Wierdl, Christopher L Morton, Linda C Harris, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
Nature Structural Biology|April 23, 2002
Structural insights into CPT-11 activation by mammalian carboxylesterasesSompop Bencharit, Christopher L Morton, Escher L Howard-Williams, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 19, 2012
Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1Ziyun Du, Michael A Whitt, Jessica Baumann, et al.
Chemistry & Biology|May 3, 2003
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibitionSompop Bencharit, Christopher L Morton, Janice L Hyatt, et al.
The Journal of Surgical Research|October 8, 2017
In-bag enzymatic splenic digestion: a novel alternative to manual morcellation?Eric D Villarreal, William Preston Hewgley, Walter H Lang, et al.
Molecular Cancer Therapeutics|August 10, 2004
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational applicationKyoung Jin P Yoon, Janice L Hyatt, Christopher L Morton, et al.
Journal of Molecular Biology|September 12, 2006
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1Sompop Bencharit, Carol C Edwards, Christopher L Morton, et al.
The Journal of Biological Chemistry|July 13, 2005
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signalingKuntebommanahalli N Thimmaiah, John B Easton, Glen S Germain, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Pediatric Blood & Cancer|December 23, 2011
Initial testing of the multitargeted kinase inhibitor pazopanib by the Pediatric Preclinical Testing ProgramStephen T Keir, Christopher L Morton, Jianrong Wu, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 23, 2003
p53-mediated regulation of expression of a rabbit liver carboxylesterase confers sensitivity to 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (CPT-11)Monika Wierdl, Christopher L Morton, Linda C Harris, et al.
Molecular Pharmacology|July 19, 2003
Carboxylesterase-mediated sensitization of human tumor cells to CPT-11 cannot override ABCG2-mediated drug resistanceMonika Wierdl, Amelia Wall, Christopher L Morton, et al.
Nature Structural Biology|April 23, 2002
Structural insights into CPT-11 activation by mammalian carboxylesterasesSompop Bencharit, Christopher L Morton, Escher L Howard-Williams, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|April 19, 2012
Inhibition of type I interferon-mediated antiviral action in human glioma cells by the IKK inhibitors BMS-345541 and TPCA-1Ziyun Du, Michael A Whitt, Jessica Baumann, et al.
Chemistry & Biology|May 3, 2003
Crystal structure of human carboxylesterase 1 complexed with the Alzheimer's drug tacrine: from binding promiscuity to selective inhibitionSompop Bencharit, Christopher L Morton, Janice L Hyatt, et al.
The Journal of Surgical Research|October 8, 2017
In-bag enzymatic splenic digestion: a novel alternative to manual morcellation?Eric D Villarreal, William Preston Hewgley, Walter H Lang, et al.
Molecular Cancer Therapeutics|August 10, 2004
Characterization of inhibitors of specific carboxylesterases: development of carboxylesterase inhibitors for translational applicationKyoung Jin P Yoon, Janice L Hyatt, Christopher L Morton, et al.
Journal of Molecular Biology|September 12, 2006
Multisite promiscuity in the processing of endogenous substrates by human carboxylesterase 1Sompop Bencharit, Carol C Edwards, Christopher L Morton, et al.
The Journal of Biological Chemistry|July 13, 2005
Identification of N10-substituted phenoxazines as potent and specific inhibitors of Akt signalingKuntebommanahalli N Thimmaiah, John B Easton, Glen S Germain, et al.
Pageof 10